Fibotran 250mg Tablet
By Fibotran
Rx
10 Tablet in a Strip

Composition
Tranexamic Acid(250mg)

Manufacturer - Kivi Labs Ltd
Khasra No. 169 Tanshipur Roorkee (U.K)

Expires on or after
April, 2026

liver
Fibotran 250mg Tablet is considered safe for individuals with liver disease. Based on the limited available data, it may not be necessary to adjust the dosage of Fibotran 250mg Tablet for patients with liver conditions. It is important to consult with your doctor regarding the use of this medication to ensure its safety and efficacy in managing your health.

kidney
Fibotran 250mg Tablet should be used cautiously in patients with kidney disease. Dose adjustment may be necessary. Please seek advice from your doctor.

alcohol
Fibotran 250mg Tablet can increase drowsiness when combined with alcohol.

driving
While taking Fibotran 250mg Tablet, it is unlikely to impact your driving ability.

pregnancy
Fibotran 250mg Tablet is generally safe to use during pregnancy based on animal studies with minimal adverse effects to the baby. Limited human studies are available.

breastfeeding
Fibotran 250mg Tablet is likely safe while breastfeeding based on limited human data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | Amino Acids, Peptides, and Analogues |
Therapeutic Class | BLOOD RELATED |
Action Class | Antifibrinolytic |
₹159
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024